Opportunities and Challenges Associated with Clinical Diagnostic Genome Sequencing A Report of the Association for Molecular Pathology
Abbreviated Journal Title
J. Mol. Diagn.
QUALITY ASSESSMENT SCHEME; RECOMBINANT-DNA; CANCER GENOME; COMMON; DISEASE; BREAST-CANCER; MUTATIONS; RISK; MEDICINE; GENES; ELECTROPHORESIS; Pathology
This report of the Whole Genome Analysis group of the Association for Molecular Pathology illuminates the opportunities and challenges associated with clinical diagnostic genome sequencing. With the reality of clinical application of next-generation sequencing, technical aspects of molecular testing can be accomplished at greater speed and with higher volume, while much information is obtained. Although this testing is a next logical step for molecular pathology laboratories, the potential impact on the diagnostic process and clinical correlations is extraordinary and clinical interpretation will be challenging. We review the rapidly evolving technologies; provide application examples; discuss aspects of clinical utility, ethics, and consent; and address the analytic, postanalytic, and professional implications. (J Mol Diagn 2012, 14:525-540; http://dx.doi.org/10.1016/j.jmoldx.2012.04.006)
Journal of Molecular Diagnostics
"Opportunities and Challenges Associated with Clinical Diagnostic Genome Sequencing A Report of the Association for Molecular Pathology" (2012). Faculty Bibliography 2010s. 3267.